Yeast RNA induces in persons and animals by parenteral or oral administration, non-specific anti-infectious resistance (tachyphylaxis), under specific conditions aggravates the course of bacterial infection, enhances the primary and secondary immunological response to antigens, induces the secondary immunological response, reduces the toxic effects of the vaccines in vivo, increase the immunogenicity and antigenicity of salmonella vaccinal strain, accelerates the reproduction and the growth of microorganisms in media with NaRNA, stimulates endogenous interferon formation and exerts therapeutic influence in the treatment of pigmentary dystrophy of the retina, radiation damage, schizophrenia, sclerosis of brain venae, etc.